Central neurocytoma: a review
MH Schmidt, ON Gottfried, CS von Koch… - Journal of neuro …, 2004 - Springer
Central neurocytomas are rare intraventricular neoplasms of the central nervous system,
compromising 0.25–0.5% of brain tumors. The diagnosis and management of these tumors …
compromising 0.25–0.5% of brain tumors. The diagnosis and management of these tumors …
Neurocytoma: a comprehensive review
MC Sharma, P Deb, S Sharma, C Sarkar - Neurosurgical review, 2006 - Springer
Central neurocytomas (CN) are uncommon tumors of the central nervous system, most
descriptions of which available in the literature are in the form of isolated case reports and …
descriptions of which available in the literature are in the form of isolated case reports and …
[图书][B] Greenfield's Neuropathology-Two Volume Set
Greenfield's Neuropathology, the world's leading neuropathology reference, provides a
comprehensive account of the pathological findings in neurological disease, their biological …
comprehensive account of the pathological findings in neurological disease, their biological …
Extraventricular neurocytomas: pathologic features and clinical outcome
DJ Brat, BW Scheithauer, CG Eberhart… - The American journal …, 2001 - journals.lww.com
Neurocytic neoplasms usually arise within the lateral ventricles, generally as circumscribed,
slowly growing masses curable by total resection. Both subtotal resection and histologic …
slowly growing masses curable by total resection. Both subtotal resection and histologic …
Central neurocytoma: management recommendations based on a 35-year experience
JL Leenstra, FJ Rodriguez, CM Frechette… - International Journal of …, 2007 - Elsevier
Purpose: To examine the outcomes of patients with histologically confirmed central
neurocytomas. Methods and Materials: The data from 45 patients with central neurocytomas …
neurocytomas. Methods and Materials: The data from 45 patients with central neurocytomas …
Central neurocytoma: a multi-disciplinary review
KA Choudhari, C Kaliaperumal, A Jain… - British Journal of …, 2009 - Taylor & Francis
Benign central neurocytoma (CN) is a rare neuronal tumour of the central nervous system
recognised since the early eighties. More than 300 articles have been published in the …
recognised since the early eighties. More than 300 articles have been published in the …
Central neurocytoma: a clinical, radiological and pathological study of nine cases
CL Chen, CC Shen, J Wang, CH Lu, HT Lee - Clinical neurology and …, 2008 - Elsevier
PURPOSE: Central neurocytoma is a rare intraventricular brain tumor that affects young
adults and presents with increased intracranial pressure secondary to obstructive …
adults and presents with increased intracranial pressure secondary to obstructive …
Prognostic factors in central neurocytomas: a multicenter study of 71 cases
A Vasiljevic, P François, A Loundou… - The American journal …, 2012 - journals.lww.com
Central neurocytoma (CN) is a rare intraventricular tumor presenting a benign histologic
appearance and favorable prognosis after surgery. In contrast,“atypical” CN is defined by a …
appearance and favorable prognosis after surgery. In contrast,“atypical” CN is defined by a …
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience
BS Imber, SE Braunstein, FY Wu… - Journal of Neuro …, 2016 - Springer
Central neurocytomas are uncommon intraventricular neoplasms whose optimal
management remains controversial due to their rarity. We assessed outcomes for a historical …
management remains controversial due to their rarity. We assessed outcomes for a historical …
Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases
F Dehghani, W Schachenmayr, A Laun, HW Korf - Acta neuropathologica, 1998 - Springer
Histopathological, immunohistochemical and clinical parameters were correlated with
survival in 89 cases of oligodendroglioma (65 patients with grade II and 24 patients with …
survival in 89 cases of oligodendroglioma (65 patients with grade II and 24 patients with …